ursodeoxycholic acid Capsules 250 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Australia , Azerbaijan , Bahrain , Belgium , Chile , Czech Republic , Denmark , Estonia , Finland , Kazakhstan , Kuwait , Latvia , Lithuania , Netherlands , New Zealand , Norway , Oman , Poland , Portugal , Qatar , Saudi Arabia , Singapore , Sweden , United Arab Emirates , United Kingdom , Vietnam
Available for
Distribution only
Comments
Product available in stock with immediate availability.
Manufacturer #1250
This pharmaceutical company is a leading player in the Baltic States with a global reach, focusing on the development and production of a wide range of pharmaceutical products. Their portfolio includes prescription medications, over-the-counter drugs, and active pharmaceutical ingredients (APIs). They have a strong presence in key regions like the EU and North America, with production lines dedicated to various therapeutic areas including heart health, diabetes, central nervous system disorders, and oncology. The company emphasizes quality assurance through GMP certifications and holds several product patents.

Manufacturer usually replies in 47 days

Ursodeoxycholic acid is a bile acid used to treat gallstones as well as to treat and prevent the progression of cystic fibrosis-related liver disorders. Suppliers of ursodeoxycholic acid market it in the form of 150mg, 250mg and 500mg oral tablets and capsules. The market for ursodeoxycholic acid is relatively competitive, populated with numerous manufacturing companies and suppliers. The largest manufacturers of ursodeoxycholic acid market globally are companies Mitsubishi Tanabe Pharma, Daewoong Chemical, and PharmaZell, Glenmark Pharmaceuticals, Dipharma Francis, Errengierre, and Grindeks. Ursodeoxycholic acid suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified ursodeoxycholic acid manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail prices per 50 (250mg) tablets of ursodeoxycholic acid fall into an approximate range of 12,00 EUR to 15,00 EUR, whereas the equivalent amount of 500mg tablets cost from 25,00 EUR to 30,00 EUR.